HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION (HIFU) IN THE TREATMENT OF PROSTATE CANCER: STATUS QUO 2014
https://doi.org/10.18027/2224-5057-2014-3-52-56
Abstract
Transrectal high-intensity focused ultrasound (HIFU) is a new, non-invasive local treatment of prostate cancer with 17 years of clinical experience, during which about 32,000 patients underwent this treatment worldwide, including2700 intheMunichclinic Harlaching, and1000 inSamaraOncologyCenter. This article shows the current status of HIFU as a noninvasive local therapy for radical or palliative approach in patients with various stages of prostate cancer, and how HIFU fits into long-term conception of the coherent multimodal treatment. This article reflects the experience of 17 years of clinical practice in two centers and results of 3700 treated patients.
About the Authors
Vyacheslav A. Solovov
Самарский областной клинический онкологический диспансер
Russian Federation
Russian Federation
Stefan Thüroff
Клиника Харлачин, Мюнхен
Germany
Germany
C. Chaussy
Клиника Харлачин, Мюнхен;
Регенсбургский Университет, Регенсбург
Germany
Germany
Michael O. Vozdvizhenskiy
Самарский областной клинический онкологический диспансер
Russian Federation
Russian Federation
Yana S. Matyash
Самарский областной клинический онкологический диспансер
Russian Federation
Russian Federation
Denis V. Fesenko
Самарский областной клинический онкологический диспансер
Russian Federation
Russian Federation
References
1. Высокоинтенсивная фокусированная ультразвуковая абляция в лечении гормонорезистентного локализованного и местнораспространенного рака предстательной железы /В.А. Соловов с соавт. // Сибирский онкологический журнал. – 2012. – Томск. – Т. № 2 (50). – С. 18–21.
2. Высокоинтенсивная фокусированная ультразвуковая абляция рака предстательной железы: 5 – летние результаты /Шаплыгин с соавтр. // Урология № 1.– 2013.– Москва.– C. 70–73.
3. Berge, V. A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results / V. Berge, E. Baco, S. J. Karlsen // Scandinavian Journal of Urology and Nephrology. – 2010. – Vol. 44 (4). – P. 223–7.
4. Chaussy, C. Local recurrence of prostate cancer after curative therapy. HIFU (Ablatherm) as a treatment option / C. G. Chaussy, S. Thüroff //Urologe A. – 2006. – Vol. 45 (10). – P.1271–1275.
5. Chaussy, C. G. Local recurrence of prostate cancer after curative therapy: HIFU (Ablatherm) as treatment option / C. G. Chaussy, S. Thüroff, T. Bergsdorf //Der Urologe A. – 2006. – Vol. 45 (10). – P. 1271–5.
6. Chaussy, C. G. Robot-assisted high-intensity focused ultrasound in Prostate Cancer / C. G. Chaussy, S. Thüroff //JEndourol. – 2010. – Vol.245. – P.843–7.
7. Control of prostate cancer by transrectal HIFU in 227 patients / L. Poissonnier et al. // Eur. Urol. – 2007. – Vol. 51. – P.381–387.
8. Eight years`experience with high-intensity focused ultrasonography for treatment of localized prostate cancer / A. Blana et al. //Urology.– 2008.– Vol. 72 (6).– P.1329–1333.
9. Expression of tumor antigens and heat-shock protein 70 in breast cancer cells after high-intensity focused ultrasound ablation / F. Wu et al.// Ann. Surg. Oncol. – 2007. – Vol. 14 (3). – P. 1237–1242.
10. First analysis of the long-term results with transrectal HIFU in patients with localized prostate cancer / A. Blana et al. // Eur. Urol. – 2008. – Vol. 53 (6). – P.1194–1201.
11. Focal therapy with high intensity focused ultrasound in the treatment of localized prostate cancer / S. Muto et al. // Jpn. J. Clin. Oncol. – 2008. – Vol.38 (3). – P. 192–199.
12. HIFU as salvage first-line treatment for palpable, TRUS evident, biopsy proven locally recurrent prostate cancer after radical prostatectomy: a pilot study /A.D. Asimakopoulos et al.// Urologic oncology. – 2012. – Vol. 30 (5). – P.577–83.
13. HIFU in Salvage Treatment of Patients with Prostate Cancer after Primary External Radiation Therapy – Status 2012 / D. Baumunk et al. //Akt Urol.– 2012.– Online-Publikation.
14. High-intensity focused ultrasound therapy for clinically localized prostate cancer / H. M. Lee et al. //Prostate Cancer Prostatic Dis. – 2006. – Vol. 9. – P. 439–443.
15. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer / P. Lu et al. //Surgery.– 2009.– Vol. 145 (3).– P. 286–293.
16. Kiel, H. J. Induction of systemic PSA-specific T cell response in prostate cancer patients after treatment with high intensive focused ultrasound / H. J. Kiel, S. Thüroff // Materials of 23th World Congress of Endourology & SWL August 23–26, 2005. Amsterdam, MP01–11.
17. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography / A. Gelet et al. // Urol. – 2004. – Vol. 63. – P. 625–629.
18. Locally recurrent prostate cancer after initial radiation therapy: early salvage high intensity focuse ultrasound improves oncologic outcomes /S. Crouzet et al. // Radiotherapy and Oncology. – 2012. – Vol 125 (2). – P. 198–202.
19. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer /F.J. Murat et al. //Eur. Urol.– 2009.– Vol.55 (3).– P. 640–647.
20. Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients / S. Crouzet et al. //Eur Urol.– 2010.– Vol. 58 (4).– P. 559–566.
21. Results and side effects of high-intensity focused ultrasound in localized prostate cancer / C. Chaussy et al. //J. Endourol. – 2001. – Vol.15. – P. 437–440.
22. Salvage Radiotherapie after high-intensity focussed ultrasound for recurrent localized prostate cancer /J. Riviere et al.// European Urology. – 2010. – Vol. 58 (4). – P.567–73.
23. Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer /V. Ficarra et al. //BJU Int. – 2006. – Vol. 98. – P. 1193–1198.
24. Thüroff, S. Evolution and outcomes of 3 MHz High intensity focused ultrasound therapy for localized prostate cancer over 15 years / S. Thüroff, C. Chaussy //The Journal of Urology®. – 2013.
25. Thüroff, S. High-Intensity focused ultrasound for prostate cancer. In: Li-Ming Su and Stephen C. Young (eds) / S. Thüroff, C. Chaussy// Early Dignosis and Treatment of Cancer: Prostate Cancer, Saunders Elsevier, Chapter 9. – 2008. – P. 177–192.
26. Thüroff, S. High-intensity focused ultrasound: complications and adverse events / S. Thüroff, C. Chaussy //Mol Urol. – 2000. – Vol. 4. – P. 183–187.
27. Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy / M. Hayashi et al.// Int. J. Urol.– 2007.– Vol. 14.– P.1048–1050.
28. Treatment Failure After Primary and Salvage Therapy for Prostate Cancer Likelihood, Patterns of Care, and Outcomes / P. K. Argawal et al. //CANCER. – 2007. – Vol. 112 (2). – P.307–14.
29. Vallancien, G. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study / G. Vallancien et al.// J Urol. – 2004. – Vol. 171 (Pt 1). – P. 2265–2267.
Review
For citations:
Solovov V.A., Thüroff S., Chaussy C., Vozdvizhenskiy M.O., Matyash Ya.S., Fesenko D.V. HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION (HIFU) IN THE TREATMENT OF PROSTATE CANCER: STATUS QUO 2014. Malignant tumours. 2014;(3):52-56. (In Russ.) https://doi.org/10.18027/2224-5057-2014-3-52-56
Views:
1046
Email this article 